Roadmap
Development timeline.
Every date is the date something happened — a patent filing, a grant award, a merged change, a released build, a completed cohort. The one item without a date is the one still ahead.
- Next
Next-generation vessel reconstruction
Angiography-derived cross-sections and lumen reconstruction, being validated against IVUS and other reference standards.
- Now
Agreement study underway
Measuring our output against the commercial 3D-QCA reference set, case by case.
- 2026
Second ESC abstract accepted
A new abstract accepted for the ESC Digital & AI Summit 2026, Basel, 12–13 November.
- Aug 2026
Fitted reference, calibration
Reference taper replaces end-window reading; catheter calibration to millimetres. Pilot build v0.1.3.
- Jul 2026
Desktop workstation
Offline QCA workstation; coronary-territory segmentation at 0.74; storage moved to EU-resident R2.
- Jun 2026
Validation cohort assembled
A dedicated validation cohort: 19 patients, 909 angiographic series, aligned to a commercial 3D-QCA reference.
- Jun 2026
QCA cascade
Vessel and stenosis masks turned into a geometric %stenosis — the measurement engine.
- Jun 2026
Segmentation baselines exceeded
Vessel 0.799 Dice / 0.807 clDice; stenosis 0.61, against a published best of 0.40 for detection.
- Jun 2026
UK IP portfolio extended
A further UK patent application, GB2613265.4, filed 9 June 2026.
- May 2026
Reproducible training infrastructure
Reproducible training infrastructure, experiment tracking, and the first ARCADE baselines.
- Nov 2025
First abstract presented at ESC
AI-driven coronary stenosis detection versus IVUS reference standard — ESC Digital & AI Summit, Berlin.
- Apr 2025
SMART: SCOTLAND award
Scottish Enterprise funds an 18-month feasibility study.
- Nov 2024
First UK patent application
"AI-Enhanced Coronary Artery Diameter Estimation", GB2416340.4, filed 6 November 2024.
- Oct 2024
Medical deep-tech programme begins
APEC turns to medical applications: AI-enhanced estimation of coronary artery diameter.
- May 2022
APEC International founded
Incorporated in England and Wales as a general engineering company.
Nothing past now carries a date, and will not until the agreement study reports. A public roadmap with a date on it is a commitment, and in medical software an optimistic one is worse than none.
The next step is a pilot site.
APEC Vox QCA is offered to hospitals as a research and validation platform, under a research-use agreement. Nothing it produces should inform a clinical decision.